Related Experiment Video
Updated: Aug 17, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is
M A Lee1, M E F Leng, R M Cooper
1Education Centre, North Tyneside General Hospital, North Shields, Newcastle upon Tyne, UK. drmarklee@hotmail.com
Abstract:
The use of opioid analgesics in renal dysfunction is potentially problematic and many patients with end stage renal disease are unable to tolerate these medications. A greater understanding of the pharmacokinetics of opioid analgesics is vital in informing safe and effective practice. Using pharmacokinetic analysis, this case study demonstrates for the first time that oxycodone and its metabolites are removed by haemodialysis. As such, care should be taken when using oxycodone in patients undergoing haemodialysis.
Related Concept Videos
Drug Concentrations: Measurements
Plasma —...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Renal Drug Excretion: Tubular Secretion

